ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

Pediatric Malignancies Program

Active
Institution
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA
Principal investigator
Eric Alejandro Sweet-Cordero
Funding
$186K
Duration
1999–2028
Open portfolio

Moonbase score

Still being scored

Abstract

Pediatric Malignancies Program: Summary/Abstract Pediatric malignancies encompass a range of tumor types, and HDFCCC Pediatric Malignancy (PE) Program members are focused on diverse cancers, including leukemias, brain tumors, and sarcoma. Many of these are embryonal tumors, cancers that begin in embryonic tissues and that often represent failure of normal differentiation. The goal of the PE Program is to advance the development of new therapies for pediatric cancer by enabling basic, translational, and clinical research with the goal of developing new effective targeted therapies for children with minimal toxicities. Specifically, PE member research focuses on (1) discovering and validating novel therapeutic targets for pediatric cancers; (2) clinically advancing new therapeutic strategies to improve outcomes for pediatric cancer patients; and (3) understanding the link between cancer and normal human development.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEP30Cancer Centers Study Section (A)[NCI-A]leukemiasmalignanciespediatriccancerspediatric cancereffective targetednormal humanprogram advance

Questions for UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.